Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular and cellular basis for diastolic dysfunction.
van Heerebeek L, Franssen CP, Hamdani N, Verheugt FW, Somsen GA, Paulus WJ. van Heerebeek L, et al. Among authors: verheugt fw. Curr Heart Fail Rep. 2012 Dec;9(4):293-302. doi: 10.1007/s11897-012-0109-5. Curr Heart Fail Rep. 2012. PMID: 22926993 Review.
Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ. van Heerebeek L, et al. Among authors: verheugt fw. Circulation. 2012 Aug 14;126(7):830-9. doi: 10.1161/CIRCULATIONAHA.111.076075. Epub 2012 Jul 17. Circulation. 2012. PMID: 22806632
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Windhausen F, Hirsch A, Sanders GT, Cornel J, Fischer J, van Straalen JP, Tijssen JG, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes investigators. Windhausen F, et al. Among authors: verheugt fw. Am Heart J. 2007 Apr;153(4):485-92. doi: 10.1016/j.ahj.2006.12.012. Am Heart J. 2007. PMID: 17383283 Clinical Trial.
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.
Montalescot G, Pitt B, Lopez de Sa E, Hamm CW, Flather M, Verheugt F, Shi H, Turgonyi E, Orri M, Vincent J, Zannad F; REMINDER Investigators; REMINDER Investigators. Montalescot G, et al. Eur Heart J. 2014 Sep 7;35(34):2295-302. doi: 10.1093/eurheartj/ehu164. Epub 2014 Apr 29. Eur Heart J. 2014. PMID: 24780614 Clinical Trial.
Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
Brouwer MA, Kievit PC, Dieker HJ, Veen G, Karreman AJ, Verheugt FW. Brouwer MA, et al. Among authors: verheugt fw. Am Heart J. 2008 Jun;155(6):1039-46. doi: 10.1016/j.ahj.2008.01.008. Epub 2008 Mar 7. Am Heart J. 2008. PMID: 18513517 Clinical Trial.
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FW, Zhu J, Granger CB, Wallentin L. Held C, et al. Among authors: verheugt fw. Eur Heart J. 2015 May 21;36(20):1264-72. doi: 10.1093/eurheartj/ehu463. Epub 2014 Dec 12. Eur Heart J. 2015. PMID: 25499871 Clinical Trial.
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.
Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, Collet JP, De Caterina R, Fox KA, Halvorsen S, Huber K, Hylek EM, Lip GY, Montalescot G, Morais J, Patrono C, Verheugt FW, Wallentin L, Weiss TW, Storey RF; ESC Thrombosis Working Group. Andreotti F, et al. Among authors: verheugt fw. Eur Heart J. 2015 Dec 7;36(46):3238-49. doi: 10.1093/eurheartj/ehv304. Epub 2015 Jul 9. Eur Heart J. 2015. PMID: 26163482 Review. No abstract available.
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.
Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GYH, Verheugt FWA, Agewall S. Niessner A, et al. Eur Heart J. 2017 Jun 7;38(22):1710-1716. doi: 10.1093/eurheartj/ehv676. Eur Heart J. 2017. PMID: 26705385 No abstract available.
619 results